HC Wainwright & Co. Reiterates Neutral on Zymeworks, Maintains $12 Price Target

BenzingaNov 22 19:54 · Ratings

Zymeworks Hold Rating: Balancing FDA Milestones With Market Valuation and Future Risks

TipRanksNov 22 19:25 · Ratings

Leerink Partners Maintains Zymeworks(ZYME.US) With Buy Rating, Raises Target Price to $26

Futu NewsNov 22 05:31 · Ratings

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

WSJNov 21 22:30

Sector Update: Health Care Stocks Rise Pre-Bell Thursday

MT NewswiresNov 21 22:13

Express News | Zymeworks Inc : Leerink Partners Raises Target Price to $26 From $25

BreakingsNov 21 21:55